FSH, bone, belly and brain.


Journal

The Journal of endocrinology
ISSN: 1479-6805
Titre abrégé: J Endocrinol
Pays: England
ID NLM: 0375363

Informations de publication

Date de publication:
01 Apr 2024
Historique:
received: 29 11 2023
accepted: 03 04 2024
medline: 6 4 2024
pubmed: 6 4 2024
entrez: 5 4 2024
Statut: aheadofprint

Résumé

The pituitary gland, often called the "master gland", orchestrates multiple effector hormonal organs and other glands by secreting various tropic hormones, which play a significant role in a myriad of physiological processes including skeletal modeling and remodeling, fat and glucose metabolism, and cognitive and psychological processes. The findings of the expression of receptors for each pituitary hormone and the hormone itself in skeleton, fat and immune cells suggested that their role is much broader than the traditional or classic role. Follicle-stimulating hormone (FSH), once believed to regulate gonadal function - gonadal development and maturation at puberty and gamete production during the fertile phase - is also found to involve in fat and bone metabolism as well as cognition, which provides us a better understanding of complex physiology. This emerging understanding of the non-reproductive role of FSH opens potential therapeutic opportunity to address detrimental health burden during and after menopause, namely osteoporosis, obesity and dementia. In this Review, we outline the current understanding of crosstalk between the pituitary, bone, adipose tissue and brain through FSH. The pre-clinical evidence from genetic and pharmacologic intervention in rodent models, and human data from population-based observation, genetic studies, and a small number of studies with interventional nature support an independent skeletal, lipogenic and cognitive effect of FSH and more.

Identifiants

pubmed: 38579764
doi: 10.1530/JOE-23-0377
pii: JOE-23-0377
doi:
pii:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Se-Min Kim (SM)

S Kim, Mount Sinai Bone Program, Mount Sinai Health System, New York, United States.

Farthath Sultana (F)

F Sultana, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Steven Sims (S)

S Sims, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Judit Gimenez-Roig (J)

J Gimenez-Roig, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Victoria Laurencin (V)

V Laurencin, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Anusha Pallapati (A)

A Pallapati, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Satish Rojekar (S)

S Rojekar, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Vitaly Ryu (V)

V Ryu, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Daria Lizneva (D)

D Lizneva, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Funda Korkmaz (F)

F Korkmaz, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Tony Yuen (T)

T Yuen, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Mone Zaidi (M)

M Zaidi, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.

Classifications MeSH